Novavax’s COVID-19 vaccine produces immune response in early study
Vaccine was generally well-tolerated with only a few mild side-effects reported
Read More
Author: Lucy Parsons
Novartis’ CAR-T therapy Kymriah hits endpoint in follicular lymphoma trial
Company expect to file regulatory submissions in 2021
Read More
Pharma’s reputation has climbed during COVID-19 pandemic, study finds
Roche, AstraZeneca, Novo Nordisk and Sanofi all climbed index rankings
Read More
AstraZeneca forges licensing agreement with Redx Pharma
AZ will pay $17m in early milestone payments for the UK biotech’s fibrotic asset
Read More
NHS adapts to pandemic with ‘COVID-friendly’ cancer treatments
Health service extends access to at-home treatments to reduce patients’ risk of contracting coronavirus
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
